BMT Peer Review Meeting

Occurs every 3 months on the 4th Thursday starting on 1/28/2021 at 12:00 PM
Thursday, January 28, 2021, 12:00 PM - 1:00 PM, Online, Grand Rapids , MI


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment.

1. Identify risk factors for the transplant type, disease population and comorbidities.
2. Increase knowledge of adverse events which contribute to patient morbidity and mortality
3. Identify prevention measures for complications
4. Identify opportunities for optimization prior to transplant

Spectrum Health Hospitals designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to cmeoffice@spectrumhealth.org.

Spectrum Health reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Spectrum Health is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CE Conference Coordinator.

Spectrum Health adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Date	Empty Column	Title
4/22/2021 12:00:00 PM	BMT Peer Review Meeting - 4/22/2021 4/22/2021 12:00:00 PM 4/22/2021 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 4/22/2021 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
7/22/2021 12:00:00 PM	BMT Peer Review Meeting - 7/22/2021 7/22/2021 12:00:00 PM 7/22/2021 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 7/22/2021 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
10/28/2021 12:00:00 PM	BMT Peer Review Meeting - 10/28/2021 10/28/2021 12:00:00 PM 10/28/2021 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 10/28/2021 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
1/27/2022 12:00:00 PM	BMT Peer Review Meeting - 1/27/2022 1/27/2022 12:00:00 PM 1/27/2022 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 1/27/2022 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
4/28/2022 12:00:00 PM	BMT Peer Review Meeting - 4/28/2022 4/28/2022 12:00:00 PM 4/28/2022 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 4/28/2022 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
7/28/2022 12:00:00 PM	BMT Peer Review Meeting - 7/28/2022 7/28/2022 12:00:00 PM 7/28/2022 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 7/28/2022 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
10/27/2022 12:00:00 PM	BMT Peer Review Meeting - 10/27/2022 10/27/2022 12:00:00 PM 10/27/2022 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 10/27/2022 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online
1/26/2023 12:00:00 PM	BMT Peer Review Meeting - 1/26/2023 1/26/2023 12:00:00 PM 1/26/2023 1:00:00 PM 15 Online False MM/DD/YYYY	BMT Peer Review Meeting - 1/26/2023 Patients undergoing Blood and Marrow Transplant or CAR T therapy experience treatment uniquely based on age, disease, donor, overall physical status and psychosocial determinants. Data is collected and trends followed for a year following treatment for all patients. For patients whose data falls out of the normal trends and/or for those who expire unexpectedly, a deeper look into the data and patient experience is helpful. Patient selection, medication regimens, complications and other dimensions are explored in hopes of improving prevention and treatment. Location: Online